18,587 articles
Christopher D. Byrne
Christopher D. Byrne is a British physician-scientist and Professor of Endocrinology and Metabolism at the University of Southampton, known for reframing fatty liver disease as a multisystem disease.
Christopher D. Harvey
Christopher D. Harvey is a systems neuroscientist and Professor of Neurobiology at Harvard Medical School who studies how cortical circuits support working memory, decision-making, and spatial navigation, using mice navigating virtual-reality corridors.
Christopher D. Lima
Christopher D. Lima is an American structural biologist who chairs the Structural Biology Program at the Sloan Kettering Institute, studying ubiquitin, SUMO, and the RNA exosome.
Christopher deCharms
Christopher deCharms (born 1966) is a neuroscientist who pioneered real-time fMRI neurofeedback, showing in a 2005 study that people could learn to control a pain-related brain region and reduce their pain.
Christopher Duggan
Christopher P. Duggan is an American pediatric gastroenterologist and nutrition researcher at Harvard Medical School and Boston Children's Hospital, known for the 2017 review Pediatric Intestinal Failure.
Christopher Dye
Christopher Dye is a British epidemiologist who worked on tuberculosis and HIV/AIDS at the World Health Organization for 22 years, then became Professor of Epidemiology at Oxford in 2018.
Christopher E. Brightling
Christopher E. Brightling, born 1968, is a British Clinical Professor of Respiratory Medicine at the University of Leicester known for asthma research and leading the national PHOSP-COVID study.
Christopher E. Henderson
Christopher E. Henderson is a Cambridge-trained neuroscientist who established GDNF as a motor neuron survival factor and built early human stem cell models of ALS.
Christopher E. Mason
Christopher E. Mason, also known as Christopher Mason, is a geneticist and computational biomedicine researcher at Weill Cornell Medicine, known for epitranscriptomics and space-omics work.
Christopher E. Pearson
Christopher E. Pearson is a Canadian human geneticist and Full Professor at the University of Toronto who studies trinucleotide repeat instability, developing small molecules that contract disease-causing DNA repeats.
Christopher F. Higgins
Christopher F. Higgins, born in 1955, is a British molecular biologist and geneticist who named the ABC transporter family and was Vice-Chancellor of Durham University from 2007 to 2014.
Christopher Heeschen
Christopher Heeschen is a German physician-scientist known for the first identification of pancreatic cancer stem cells, now a professor at Shanghai Jiao Tong University School of Medicine and director of a pancreatic cancer laboratory in Italy.
Christopher Hourigan
Christopher Simon Hourigan (DM, DPhil, FRCP) is an oncologist and physician-scientist known for founding AML measurable residual disease (MRD) testing, the 2019 JCO phase 3 trial, Pre-MEASURE, and MEASURE (NCT05224661); formerly NHLBI tenured investigator, now Virginia Tech Fralin Cancer Research Center director.
Christopher I. Moore
Christopher I. Moore is a neuroscientist and the Adam and Margaret Korn Professor at Brown University's Carney Institute, known for showing that fast-spiking interneurons drive gamma rhythms.
Christopher J. Bulpitt
Christopher J. Bulpitt is a physician-epidemiologist and Emeritus Professor of Geriatric Medicine at Imperial College London, chief investigator of the HYVET trial of treating hypertension in people aged 80 and over.
Christopher J. Hawkey
Christopher J. Hawkey, also known as C J Hawkey, is a British gastroenterologist at the University of Nottingham whose trials established proton pump inhibitor prophylaxis against ulcers caused by NSAIDs and aspirin.
Christopher J. Howe
Christopher J. Howe is a molecular biologist at the University of Cambridge, Professor of Plant and Microbial Biochemistry since 2005, known for biophotovoltaics and chloroplast genome research.
Christopher J. Lamb
Christopher John Lamb (1950–2009) was a British plant biologist who made seminal contributions to plant–pathogen interactions, directing the Salk Institute's Plant Biology Laboratory and the John Innes Centre.
Christopher J. Leaver
Christopher J. Leaver is a plant molecular biologist who was Sibthorpian Professor of Plant Sciences at Oxford from 1990 to 2007, known for pioneering research on the plant mitochondrial genome.
Christopher J. Lord
Christopher J. Lord is a British cancer scientist at the Institute of Cancer Research in London, known for work linking BRCA mutations to PARP inhibitor drugs.
Christopher J. Marshall
Christopher J. Marshall (1949–2015) was a British cell biologist and cancer researcher at the Institute of Cancer Research, London, known for discovering the NRAS oncogene and mapping Ras signaling.
Christopher J. O’Donnell
Christopher J. O'Donnell is an American cardiologist and physician-scientist who led cardiovascular genomics research at the Framingham Heart Study and NHLBI, then joined Novartis in 2021.
Christopher J. Potter
Christopher J. Potter is a professor of neuroscience at Johns Hopkins University School of Medicine, known for the Q system and for studying how malaria mosquitoes smell.
Christopher J. Sweeney
Christopher J. Sweeney is an Australian-trained medical oncologist and inaugural Director of the South Australian immunoGENomics Cancer Institute, known for leading the CHAARTED and ENZAMET trials.
Christopher J.L. Murray
Christopher J.L. Murray is a physician and epidemiologist who co-created the Global Burden of Disease study and the DALY metric, and founded the Institute for Health Metrics and Evaluation in 2007.
Christopher K. Glass
Christopher K. Glass is an American physician-scientist, Distinguished Professor of Cellular and Molecular Medicine at UC San Diego since 1989, known for discovering transcriptional mechanisms regulating macrophage inflammation in atherosclerosis, diabetes, and neurodegeneration.
Christopher M. Booth
Christopher M. Booth is a Canadian medical oncologist and clinician-scientist at Queen's University in Kingston, Ontario, who led the CHALLENGE trial of exercise after colon cancer chemotherapy.
Christopher M. Counter
Christopher M. Counter is a molecular cancer biologist at the Duke University School of Medicine, where he holds the George Barth Geller Distinguished Professorship of Pharmacology and studies RAS-driven tumors.
Christopher M. Dobson
Christopher M. Dobson (1949–2019) was a British chemical and structural biologist at Cambridge whose work established protein misfolding and amyloid disease as a central field.
Christopher M. O’Connor
Christopher M. O'Connor is an American cardiologist and clinical trialist who has led the Inova Heart and Vascular Institute since 2015 after a long career at Duke University.